The American Academy of Neurology has issued its recommendations on the use of natalizumab in the treatment of multiple sclerosis (Goodin et al. Neurology 2008;71:766-773).
Read More
Neurology
Role of autoimmunity, inflammation in atherosclerosis in young women
January 6, 2009REPORT FROM THE 6TH WORLD STROKE CONGRESS – The Atherosclerosis Risk Factors in Female Youngsters (ARFY) study reports that atherosclerosis in young women appears to develop as a result of autoimmune and inflammatory factors rather than because of classical risk factors (Zangerle et al. Abstract P002-474).
Significance of elevated troponin in acute stroke
January 6, 2009REPORT FROM THE 6TH WORLD STROKE CONGRESS – Approximately 1 in 5 acute stroke patients will demonstrate elevated troponin levels, which are associated with an increased risk of disability or mortality, according to a systematic review of the literature (Kerr et al. PS1).
Unruptured intracranial aneurysms: to treat or not?
January 6, 2009REPORT FROM THE 6TH WORLD STROKE CONGRESS – Larger aneurysms and those in the posterior circulation and posterior communicating artery are at greatest risk of rupture, according to new data from the International Study of Unruptured Intracranial Aneurysms presented at the World Stroke Congress (Brown et al. Abstract FC02-04).
Read More
Anticholinergic drug use may be associated with cognitive decline
December 10, 2008REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – Anticholinergic agents (e.g. tolterodine, oxybutynin) are frequently prescribed in the elderly but may produce an accelerated cognitive decline, according to a U.S. study (Janos et al. Abstract T-35).
Read More